HKSE · 1652.HK
Fusen Pharmaceutical Company Limited
HK$1.03+HK$0.03 (+3.0%)
Fusen Pharmaceutical Company Limited’s quoted price sits in the lower half of its reported 52-week range, 28.47% below the high.
Loading market information…
HKSE · 1011.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:18 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
China NT Pharma Group Company Limited’s quoted price sits in the lower half of its reported 52-week range, 75.5% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
China NT Pharma Group Company Limited’s forward annual dividend is HK$0.04 per share, paid annual. The forward yield is 14.29% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow China NT Pharma Group Company Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
China NT Pharma Group Company Limited, operating alongside its various subsidiaries, is dedicated to the full spectrum of pharmaceutical activities. This encompasses the research, development, manufacturing, commercialization, and distribution of medicinal products, serving both the People's Republic of China and international territories. The firm develops and markets prescription medications addressing a diverse array of medical conditions, including oncological and hematological diseases, gastrointestinal disorders, central nervous system afflictions, and respiratory illnesses, among other therapeutic fields. In addition to these specialized drugs, it also produces and distributes its proprietary "NT" branded products and generic formulations. Furthermore, the group extends its offerings to include marketing and promotional assistance for suppliers, alongside providing logistics and consulting solutions. Established in 1995, the company maintains its corporate headquarters in Suzhou, People's Republic of China.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:36 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| HK$133.55M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$1.03+HK$0.03 (+3.0%)
Fusen Pharmaceutical Company Limited’s quoted price sits in the lower half of its reported 52-week range, 28.47% below the high.
HK$0.63-HK$0.02 (-2.34%)
Zhongzhi Pharmaceutical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 36.22% below the high.
HK$0.71+HK$0.03 (+3.65%)
Vincent Medical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 34.86% below the high.
HK$0.36+HK$0.02 (+5.88%)
Wai Yuen Tong Medicine Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 26.53% below the high.
HK$0.62-HK$0.03 (-3.88%)
Yunkang Group Limited’s quoted price sits in the lower half of its reported 52-week range, 50.4% below the high.
HK$0.52-HK$0.01 (-0.95%)
Austar Lifesciences Limited’s quoted price sits in the lower half of its reported 52-week range, 59.06% below the high.
HK$0.33-HK$0.01 (-2.94%)
Modern Chinese Medicine Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 89.88% below the high.
HK$0.17-HK$0.00 (-1.15%)
Rainmed Medical Limited’s quoted price sits in the lower half of its reported 52-week range, 47.88% below the high.
